Medtronic plc (MDT)
Medtronic's Mixed Q4 Earnings Report
Medtronic's top line saw growth in Q4 and full-year, but that growth disappeared in the bottom-line figures. Medtronic management was positive in its outlook for fiscal 25 with projected organic revenue growth of 4%-5%.
Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.
Medtronic plc (MDT) Q4 2024 Earnings Call Transcript
Medtronic plc (NYSE:MDT ) Q4 2024 Earnings Conference Call May 23, 2024 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head, Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Executive Vice President and Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Brett Wall - Executive Vice President and President, Neuroscience Portfolio Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit Que Dallara - Executive Vice President and President, Diabetes Operating Unit Conference Call Participants Travis Steed - Bank of America Securities Robert Marcus - JPMorgan Vijay Kumar - Evercore ISI Lawrence Biegelsen - Wells Fargo Pito Chickering - Deutsche Bank Joshua Jennings - Cowen and Company Richard Newitter - Truist Securities Matt Miksic - Barclays Ryan Weispfenning Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and I appreciate that you're joining us this morning for our Fiscal '24 Fourth Quarter Video Earnings Webcast.
Why Medtronic Stock Slumped Today
Medtronic beat on sales and earnings and gave exactly the guidance that Wall Street expected. Its stock dropped today anyway.
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT issued roughly in-line guidance for the full year.
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT issued roughly in-line guidance for the full year.
Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates
Medtronic (MDT) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.57 per share a year ago.
Medtronic's stock rises after earnings beat expectations and the dividend was raised
Shares of Medtronic PLC MDT, +0.69% rallied 1.3% in premarket trading Thursday, after the medical device and therapies company reported fiscal fourth-quarter profit and revenue that rose above expectations, and lifted its dividend. Net income for the quarter to April 26 fell to $654 million, or 49 cents a share, from $1.19 billion, or 88 cents a share, in the same period a year ago.
Medtronic beats quarterly profit estimates on medical devices strength
Health tech firm Medtronic beat Wall Street estimates for quarterly profit on Thursday, aided by a post-pandemic pickup in surgical volumes at hospitals that boosted demand for its medical devices.
Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade
Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic Medtronic stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to meet the street estimates.
